Xue Z, Lu J, Lin J, Huang C M, Li P, Xie J W, Wang J B, Lin J X, Chen Q Y, Zheng C H
Department of Gastric Surgery, Key Laboratory of Gastrointestinal Cancer (Ministry of Education), Fujian Medical University Union Hospital, Fuzhou 350004, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Apr 25;25(4):327-335. doi: 10.3760/cma.j.cn441530-20220105-00010.
To establish a neural network model for predicting lymph node metastasis in patients with stage II-III gastric cancer. Case inclusion criteria: (1) gastric adenocarcinoma diagnosed by pathology as stage II-III (the 8th edition of AJCC staging); (2) no distant metastasis of liver, lung and abdominal cavity in preoperative chest film, abdominal ultrasound and upper abdominal CT; (3) undergoing R0 resection. Case exclusion criteria: (1) receiving preoperative neoadjuvant chemotherapy or radiotherapy; (2) incomplete clinical data; (3) gastric stump cancer.Clinicopathological data of 1231 patients with stage II-III gastric cancer who underwent radical surgery at the Fujian Medical University Union Hospital from January 2010 to August 2014 were retrospectively analyzed. A total of 1035 patients with lymph node metastasis were confirmed after operation, and 196 patients had no lymph node metastasis. According to the postoperative pathologic staging. 416 patients (33.8%) were stage Ⅱ and 815 patients (66.2%) were stage III. Patients were randomly divided into training group (861/1231, 69.9%) and validation group (370/1231, 30.1%) to establish an artificial neural network model (N+-ANN) for the prediction of lymph node metastasis. Firstly, the Logistic univariate analysis method was used to retrospectively analyze the case samples of the training group, screen the variables affecting lymph node metastasis, determine the variable items of the input point of the artificial neural network, and then the multi-layer perceptron (MLP) to train N+-ANN. The input layer of N+-ANN was composed of the variables screened by Logistic univariate analysis. Artificial intelligence analyzed the status of lymph node metastasis according to the input data and compared it with the real value. The accuracy of the model was evaluated by drawing the receiver operating characteristic (ROC) curve and obtaining the area under the curve (AUC). The ability of N+-ANN was evaluated by sensitivity, specificity, positive predictive values, negative predictive values, and AUC values. There were no significant differences in baseline data between the training group and validation group (all >0.05). Univariate analysis of the training group showed that preoperative platelet to lymphocyte ratio (PLR), preoperative systemic immune inflammation index (SII), tumor size, clinical N (cN) stage were closely related to postoperative lymph node metastasis. The N+-ANN was constructed based on the above variables as the input layer variables. In the training group, the accuracy of N+-ANN for predicting postoperative lymph node metastasis was 88.4% (761/861), the sensitivity was 98.9% (717/725), the specificity was 32.4% (44/136), the positive predictive value was 88.6% (717/809), the negative predictive value was 84.6% (44/52), and the AUC value was 0.748 (95%CI: 0.717-0.776). In the validation group, N+-ANN had a prediction accuracy of 88.4% (327/370) with a sensitivity of 99.7% (309/310), specificity of 30.0% (18/60), positive predictive value of 88.0% (309/351), negative predictive value of 94.7% (18/19), and an AUC of 0.717 (95%CI:0.668-0.763). According to the individualized lymph node metastasis probability output by N+-ANN, the cut-off values of 0-50%, >50%-75%, >75%-90% and >90%-100% were applied and patients were divided into N0 group, N1 group, N2 group and N3 group. The overall prediction accuracy of N+-ANN for pN staging in the training group and the validation group was 53.7% and 54.1% respectively, while the overall prediction accuracy of cN staging for pN staging in the training group and the validation group was 30.1% and 33.2% respectively, indicating that N+-ANN had a better prediction than cN stage. The N+-ANN constructed in this study can accurately predict postoperative lymph node metastasis in patients with stage Ⅱ-Ⅲ gastric cancer. The N+-ANN based on individualized lymph node metastasis probability has better accurate prediction for pN staging as compared to cN staging.
建立用于预测Ⅱ-Ⅲ期胃癌患者淋巴结转移的神经网络模型。病例纳入标准:(1)经病理诊断为Ⅱ-Ⅲ期(AJCC第8版分期)的胃腺癌;(2)术前胸部X线、腹部超声及上腹部CT检查未发现肝、肺及腹腔远处转移;(3)接受R0切除。病例排除标准:(1)接受术前新辅助化疗或放疗;(2)临床资料不完整;(3)胃残端癌。回顾性分析2010年1月至2014年8月在福建医科大学附属协和医院接受根治性手术的1231例Ⅱ-Ⅲ期胃癌患者的临床病理资料。术后共确诊1035例有淋巴结转移患者,196例无淋巴结转移。根据术后病理分期,416例(33.8%)为Ⅱ期,815例(66.2%)为Ⅲ期。将患者随机分为训练组(861/1231,69.9%)和验证组(370/1231,30.1%),建立用于预测淋巴结转移的人工神经网络模型(N+-ANN)。首先,采用Logistic单因素分析方法对训练组病例样本进行回顾性分析,筛选影响淋巴结转移的变量,确定人工神经网络输入点的变量项,然后采用多层感知器(MLP)训练N+-ANN。N+-ANN的输入层由Logistic单因素分析筛选出的变量组成。人工智能根据输入数据分析淋巴结转移状态并与实际值进行比较。通过绘制受试者工作特征(ROC)曲线并获得曲线下面积(AUC)评估模型的准确性。通过敏感性、特异性、阳性预测值、阴性预测值和AUC值评估N+-ANN的能力。训练组和验证组的基线数据无显著差异(均>0.05)。训练组单因素分析显示,术前血小板与淋巴细胞比值(PLR)、术前全身免疫炎症指数(SII)、肿瘤大小、临床N(cN)分期与术后淋巴结转移密切相关。基于上述变量作为输入层变量构建N+-ANN。在训练组中,N+-ANN预测术后淋巴结转移的准确率为88.4%(761/861),敏感性为98.9%(717/725),特异性为32.4%(44/136),阳性预测值为88.6%(717/809),阴性预测值为84.6%(44/52),AUC值为0.748(95%CI:0.717-0.776)。在验证组中,N+-ANN的预测准确率为88.4%(327/370),敏感性为99.7%(309/310),特异性为30.0%(18/60),阳性预测值为88.0%(309/351),阴性预测值为94.7%(18/19),AUC为0.717(95%CI:0.668-0.763)。根据N+-ANN输出的个体化淋巴结转移概率,应用0-50%、>50%-75%、>75%-90%和>90%-100%的截断值将患者分为N0组、N1组、N2组和N3组。训练组和验证组中N+-ANN对pN分期的总体预测准确率分别为53.7%和54.1%,而训练组和验证组中cN分期对pN分期的总体预测准确率分别为30.1%和33.2%,表明N+-ANN比cN分期具有更好的预测能力。本研究构建的N+-ANN能够准确预测Ⅱ-Ⅲ期胃癌患者术后淋巴结转移。基于个体化淋巴结转移概率的N+-ANN与cN分期相比,对pN分期具有更好的准确预测能力。